63 related articles for article (PubMed ID: 15367043)
21. Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome.
Rutherford BR; Wager TD; Roose SP
Curr Psychiatry Rev; 2010 Feb; 6(1):1-10. PubMed ID: 24812548
[TBL] [Abstract][Full Text] [Related]
22. Improving study design for antidepressant effectiveness assessment.
Naudet F; Millet B; Reymann JM; Falissard B
Int J Methods Psychiatr Res; 2013 Sep; 22(3):217-31. PubMed ID: 24038333
[TBL] [Abstract][Full Text] [Related]
23. Placebo and the new physiology of the doctor-patient relationship.
Benedetti F
Physiol Rev; 2013 Jul; 93(3):1207-46. PubMed ID: 23899563
[TBL] [Abstract][Full Text] [Related]
24. Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study.
Khajehnasiri F; Mortazavi SB; Allameh A; Akhondzadeh S
J Clin Biochem Nutr; 2013 Jul; 53(1):36-40. PubMed ID: 23874068
[TBL] [Abstract][Full Text] [Related]
25. A model of placebo response in antidepressant clinical trials.
Rutherford BR; Roose SP
Am J Psychiatry; 2013 Jul; 170(7):723-33. PubMed ID: 23318413
[TBL] [Abstract][Full Text] [Related]
26. A randomized, prospective pilot study of patient expectancy and antidepressant outcome.
Rutherford BR; Marcus SM; Wang P; Sneed JR; Pelton G; Devanand D; Duan N; Roose SP
Psychol Med; 2013 May; 43(5):975-82. PubMed ID: 22971472
[TBL] [Abstract][Full Text] [Related]
27. Patients' treatment expectancies in clinical trials of antidepressants versus psychotherapy for depression: a study using hypothetical vignettes.
Gaudiano BA; Hughes JA; Miller IW
Compr Psychiatry; 2013 Jan; 54(1):28-33. PubMed ID: 22794942
[TBL] [Abstract][Full Text] [Related]
28. Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression.
Severus E; Seemüller F; Berger M; Dittmann S; Obermeier M; Pfennig A; Riedel M; Frangou S; Möller HJ; Bauer M
BMC Med; 2012 Jul; 10():67. PubMed ID: 22747667
[TBL] [Abstract][Full Text] [Related]
29. Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis.
Rutherford BR; Sneed JR; Roose SP
J Affect Disord; 2012 Sep; 140(1):57-65. PubMed ID: 22387053
[TBL] [Abstract][Full Text] [Related]
30. Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.
Rutherford BR; Sneed JR; Tandler JM; Rindskopf D; Peterson BS; Roose SP
J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):782-95. PubMed ID: 21784298
[TBL] [Abstract][Full Text] [Related]
31. The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder.
Lewin AB; Peris TS; Lindsey Bergman R; McCracken JT; Piacentini J
Behav Res Ther; 2011 Sep; 49(9):536-43. PubMed ID: 21723534
[TBL] [Abstract][Full Text] [Related]
32. Lessons learned from placebo groups in antidepressant trials.
Mora MS; Nestoriuc Y; Rief W
Philos Trans R Soc Lond B Biol Sci; 2011 Jun; 366(1572):1879-88. PubMed ID: 21576145
[TBL] [Abstract][Full Text] [Related]
33. A new paradigm for the prediction of antidepressant treatment response.
Leuchter AF; Cook IA; Hunter AM; Korb AS
Dialogues Clin Neurosci; 2009; 11(4):435-46. PubMed ID: 20135901
[TBL] [Abstract][Full Text] [Related]
34. Identifying risk for attrition during treatment for depression.
Warden D; Trivedi MH; Wisniewski SR; Lesser IM; Mitchell J; Balasubramani GK; Fava M; Shores-Wilson K; Stegman D; Rush AJ
Psychother Psychosom; 2009; 78(6):372-9. PubMed ID: 19738403
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant study design affects patient expectancy: a pilot study.
Rutherford B; Sneed J; Devanand D; Eisenstadt R; Roose S
Psychol Med; 2010 May; 40(5):781-8. PubMed ID: 19732481
[TBL] [Abstract][Full Text] [Related]
36. Study design affects participant expectations: a survey.
Rutherford BR; Rose SA; Sneed JR; Roose SP
J Clin Psychopharmacol; 2009 Apr; 29(2):179-81. PubMed ID: 19512982
[TBL] [Abstract][Full Text] [Related]
37. Preference in random assignment: implications for the interpretation of randomized trials.
Macias C; Gold PB; Hargreaves WA; Aronson E; Bickman L; Barreira PJ; Jones DR; Rodican CF; Fisher WH
Adm Policy Ment Health; 2009 Sep; 36(5):331-42. PubMed ID: 19434489
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics and pharmacovigilance.
Howland RH
Drug Saf; 2009; 32(3):265-70. PubMed ID: 19338384
[No Abstract] [Full Text] [Related]
39. Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.
Rutherford BR; Sneed JR; Roose SP
Psychother Psychosom; 2009; 78(3):172-81. PubMed ID: 19321970
[TBL] [Abstract][Full Text] [Related]
40. The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill.
Bertisch SM; Legedza AR; Phillips RS; Davis RB; Stason WB; Goldman RH; Kaptchuk TJ
J Eval Clin Pract; 2009 Feb; 15(1):14-9. PubMed ID: 19239577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
